The platform offers evidence-based guidance for navigating regenerative peptide applications
Insufficient evidence of effectiveness The nominated clinical use FDA evaluated was ulcerative colitis
Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
Structural Classification: Quinoline derivative
Combines four well-researched peptides Comes in COA-verified lyophilized powder form for purity and stability $140.00Purchase & earn 140 points
Request the COA and confirm it includes HPLC quantification, MS molecular weight confirmation matched to the stated form, a named third-party lab, and a batch number matching your bottle